EGF-SNX3-EGFR axis drives tumor progression and metastasis in triple-negative breast cancers. Cicek E, Circir A, Oyken M, Akbulut Caliskan O, et al. Oncogene 2022;41:220-232.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cicek E, Circir A, Oyken M, Akbulut Caliskan O, et al. EGF-SNX3-EGFR axis drives tumor progression and metastasis in triple-negative breast cancers. Oncogene 2022;41:220-232.
PMID: 34718348